Nasdaq

Ikena Oncology Announces 1-for-12 Reverse Stock Split and Merger with Inmagene Biopharmaceuticals, to Trade as ImageneBio, Inc. on Nasdaq Under Ticker "IMA"

Approval of the merger with Inmagene demonstrates strong shareholder support and confidence in the company's strategic direction. The reverse stock split aims to improve the market perception of the ...

RYVYL Inc.: RYVYL Announces Stockholder Approval of Annual Meeting Proposals; Reverse Stock Split Process Commences to Remedy Nasdaq Delisting Notice

Summary of Steps Taken to Maintain Listing Compliance SAN DIEGO, CA, Dec. 17, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL" or the "Company") today announced that stockholders approved ...
Nasdaq

Vincerx Pharma, Inc. Terminates Reverse Merger Agreement and Will Explore Strategic Alternatives

Vincerx Pharma, Inc. announced the termination of a binding Term Sheet for a reverse merger with Oqory, Inc. and Vivasor, Inc., leading the board of directors to reevaluate the company's strategic ...
Seeking Alpha

NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem

ZURICH, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NLSP) (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery ...